NovoCure Ltd — Director's Dealing 2019

Jul 30, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-07-26

Reporting Person: Shah Pritesh (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-26	Ordinary Shares	M	12500	$19.25	Acquired	89476	Direct
2019-07-26	Ordinary Shares	S	578	$75.038	Disposed	88898	Direct
2019-07-26	Ordinary Shares	S	2710	$76.39	Disposed	86188	Direct
2019-07-26	Ordinary Shares	S	2800	$77.277	Disposed	83388	Direct
2019-07-26	Ordinary Shares	S	2455	$78.676	Disposed	80933	Direct
2019-07-26	Ordinary Shares	S	3857	$79.411	Disposed	77076	Direct
2019-07-26	Ordinary Shares	S	100	$80.06	Disposed	76976	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-26	Options to buy Ordinary Shares	$19.25	M	12500	Acquired	2027-07-25	Options to buy Ordinary Shares (12500)	Direct

Footnotes

F1: These shares were acquired pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah.

F2: On July 26, 2019, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, he sold these shares in multiple trades at prices ranging from $74.80 to $75.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3: On July 26, 2019, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, he sold these shares in multiple trades at prices ranging from $75.86 to $76.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F4: On July 26, 2019, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, he sold these shares in multiple trades at prices ranging from $76.88 to $77.81. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F5: On July 26, 2019, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, he sold these shares in multiple trades at prices ranging from $77.94 to $78.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F6: On July 26, 2019, pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, he sold these shares in multiple trades at prices ranging from $78.97 to $79.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

F7: Fully vested as of the date hereof.